Nebulized fentanyl study in healthy volunteers
Part of Brain & nervous system, Pain clinical trials.
This trial tests a nebulized (inhaled mist) form of fentanyl in healthy volunteers to see how it works in the body. It is a first-in-human study of the drug given through a nebulizer, which might help people with acute pain in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 68 years old
- Your body mass index (BMI) should be between 19 and 29
- You cannot have chronic pain or take long-term painkillers/narcotics
- You must have no serious chronic health problems (like heart, lung, kidney issues) or conditions that affect your breathing
- Women able to become pregnant must use a very effective method of birth control and have a negative pregnancy test
- You must not have any recent infections (like COVID-19 or flu) within the past 15 days
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to give a nasal spray of fentanyl (a strong painkiller) to premature babies before their routine eye exams for ROP. It aims to see if this medicine reduces pain and discomfort during the exam better than current standard care.
This study compares two different nasal spray pain medicines (sufentanil and ketamine) to see which works better and is safer for children with severe pain from injuries, like a broken arm or leg.
This study tests a new drug, CS-1103, to see if it can safely help reverse the effects of fentanyl (a strong opioid) even after a naloxone block. Healthy volunteers who have used opioids before will be given fentanyl and then the study drug, while researchers monitor safety and how the drug works.
This study looks back at children who already received fentanyl nasal spray for pain in the emergency department. It aims to see how well this method worked for treating sudden pain in children.
This trial tests a way to quickly start buprenorphine (a medication for opioid addiction) in an outpatient clinic for people who use fentanyl. It aims to make starting treatment easier and faster, without needing to go through full withdrawal first.
This trial compares giving fentanyl as a nasal spray versus an injection to help preterm babies during painful procedures like placing a central line, inserting a breathing tube, or a spinal tap. The goal is to see which method works better and is safer.
Hear when a new Emergencies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.